Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study

January 23, 2017 updated by: Duke University

Personalized Health Planning in Shared Medical Appointments for Individuals With Type II

The primary aim of this study is to examine the feasibility of implementing an evidence based patient engagement strategy, known as personalized health planning (PHP), in the context of a a shared medical appointment (SMA) for individuals with type II diabetes in a primary care setting.

Study Overview

Detailed Description

All data for the prospective portion of this study was done being collected in September 2016. The retrospective chart review will collect data up until March of 2017 (six months after the last subject completed the prospective phase by attending their last SMA session).

Study Type

Interventional

Enrollment (Actual)

33

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27705
        • Duke Family Medicine Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A diagnosis of Type 2 diabetes within the last year
  • A current patient at Duke Family Medicine.
  • An A1C score greater than 7 and less than 14.

Exclusion Criteria:

  • A diagnosis of Pre-diabetes
  • A diagnosis of Type I diabetes
  • Individuals with amputations as a result of their diabetes are excluded form this study.
  • Individuals with renal dialysis will not be included in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard Shared Medical Appointment
The SMA group will be a standard shared diabetes medical appointment group consisting of up to 10 patients that utilizes the design and curriculum of the SMAs that are currently being held at the Duke Family Medicine Center.
Experimental: Personalized Health Planning Shared Medical Appointment
The PHP SMA group will combine personalized health planning with a modified version of the standard shared diabetes medical appointment. Modifications include: a self-assessment of health status, greater emphasis on a collaborative patient-provider health goal-setting process, a plan to meet goals, a mindfulness practice included in each session, and the creation of a 'personalized health plan' participant notebook for each individual to document health goals and track progress to review at each session. The participant notebook also includes educational handouts and worksheets to complement the educational curriculum.
The PHP SMA group will combine personalized health planning with a modified version of the standard shared diabetes medical appointment. Modifications include: a self-assessment of health status, greater emphasis on a collaborative patient-provider health goal-setting process, a plan to meet goals, a mindfulness practice included in each session, and the creation of a 'personalized health plan' participant notebook for each individual to document health goals and track progress to review at each session. The participant notebook also includes educational handouts and worksheets to complement the educational curriculum
No Intervention: Retrospective
A retrospective chart review will be conducted once all participants (both SMA group and PHP SMA group) complete the intervention. The retrospective chart review will collect healthcare utilization data six months prior, during, and after each subject's participation in the SMA.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Feasibility measured using a patient satisfaction survey
Time Frame: 12 months
12 months
Change in patient activation measured using the patient activation measure
Time Frame: baseline; 6 months; 12 months
baseline; 6 months; 12 months
Change in self-management of diabetes self-efficacy using the Diabetes Empowerment Scale
Time Frame: baseline; 6 months; 12 months
baseline; 6 months; 12 months
Change in diabetes self efficacy using the 1-item diabetes self-efficacy scale
Time Frame: baseline; 6 months; 12 months
baseline; 6 months; 12 months
Change in A1C using the A1C blood test
Time Frame: baseline; 3 months; 6 months; 9 months; 12 months
baseline; 3 months; 6 months; 9 months; 12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in depression screening score using the Patient Health Questionnaire (PHQ-9)
Time Frame: baseline; 6 months; 12 months
baseline; 6 months; 12 months
Change in functional health and well-being using the short form health survey
Time Frame: baseline; 6 months; 12 months
baseline; 6 months; 12 months
Change in general self-rated health using the general self rated health survey (GSRH)
Time Frame: baseline; 6 months; 12 months
baseline; 6 months; 12 months
Change in health goal progress using a goal progress visual analog scale
Time Frame: 3 months; 10 months
3 months; 10 months
change in body mass index using weight and height measurements
Time Frame: baseline; 1 months; 2 months; 3 months; 5 months; 8 months; 10 months; 12 months
baseline; 1 months; 2 months; 3 months; 5 months; 8 months; 10 months; 12 months
change in blood pressure using blood pressure measurement
Time Frame: baseline; 1 months; 2 months; 3 months; 5 months; 8 months; 10 months; 12 months
baseline; 1 months; 2 months; 3 months; 5 months; 8 months; 10 months; 12 months
Change in low-density lipoprotein cholesterol (LDL) using LDL measurement
Time Frame: baseline; 6 months; 12 months
baseline; 6 months; 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Sharon Hull, MD MPH, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2015

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

September 1, 2016

Study Registration Dates

First Submitted

June 11, 2015

First Submitted That Met QC Criteria

June 11, 2015

First Posted (Estimate)

June 15, 2015

Study Record Updates

Last Update Posted (Estimate)

January 24, 2017

Last Update Submitted That Met QC Criteria

January 23, 2017

Last Verified

January 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type II Diabetes

Clinical Trials on Personalized Health Planning Shared Medical Appointment

Subscribe